Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nancy Lynch

Hand Surgery San Mateo, CA Medical Doctor

NPI 1508161472 CMS profile 68360

210 42Nd Ave, San Mateo, CA 94403

Open in the dashboard

General payments

$861,726

93 records reported · program years 2019–2025

Research payments

$43,456

Paid to them · 8 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nancy Lynch of San Mateo, CA is reported in the CMS Open Payments database as having received $861,726 across 93 general payments and $43,456 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $144,388 15
2024 General $267,525 20
2023 General $147,434 22
2022 General $62,700 13
2021 General $1,013 1
2021 Research $43,456 8
2020 General $59,513 10
2019 General $179,155 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nancy Lynch
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Nancy Lynch were reported at $144,388. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Nancy Lynch Hand Surgery median Middle half National median
2019 $179,155 $383 $106–$1,905 $163
2020 $59,513 $172 $51–$1,268 $114
2021 $1,013 $263 $71–$1,591 $132
2022 $62,700 $336 $87–$1,938 $149
2023 $147,434 $233 $81–$1,114 $160
2024 $267,525 $258 $88–$1,203 $164
2025 $144,388 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Jazz Pharmaceuticals Inc. $581,976 57 payments
  2. Ferring International Pharmascience Center US $239,663 22 payments
  3. Bioventus LLC $40,050 12 payments
  4. Atricure, Inc. $20 1 payment
  5. Myoscience Inc. $17 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $861,262 86 payments
  2. Travel and Lodging $376 3 payments
  3. Food and Beverage $88 4 payments
Products named General payments · program years 2019–2025
  1. XYWAV $531,651 50 payments
  2. SUNOSI $50,325 7 payments
  3. Exogen Ultrasound Bone Healing System $31,050 6 payments
  4. DUROLANE $5,288 3 payments
  5. None $3,713 3 payments
  6. Amplex $1,013 1 payment
  7. ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) $40 2 payments
  8. iovera System $17 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Jazz Pharmaceuticals Inc. $36,975 4 payments
  2. Bioventus LLC $6,481 4 payments

Records

101 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record